TAM PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of TAM PHARMA is 2.9% (moderate). The 2025 annual accounts show equity of €44k and a net result of €21k. Equity is growing by ~69.2% per year across the filed fiscal years. Its solvency ranks better than 79% of 18280 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+1
Solvency95▲+19
Growth78=
Track record94
Bankruptcy probability, 12 months
2.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €3k at 30 days acceptable
Liquidity ample (current ratio 3.17 against 1.89 in 2024; short-term debt: 30.5% and cash: 32.4% of total assets), and 30.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
69.5%
Return on assets
33.2%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 29-04-2026, 1 day ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
1 d early
2024
20 d late
2023
23 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€44k▲ 91.6%
2024 · €23k
2023: €12k
2024: €23k
2023 → 2025
Total assets
€63k▲ 40.8%
2024 · €45k
2023: €23k
2024: €45k
2023 → 2025
Net result
€21k▲ 95.9%
2024 · €11k
2023: €10k
2024: €11k
2023 → 2025
Working capital
€42k▲ 113%
2024 · €20k
2023: €8k
2024: €20k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€12k-€23k▲ 87.8%€44k▲ 91.6%
Operating result€16k-€15k▼ 4.5%€28k▲ 84.3%
Net result€10k-€11k▲ 5.0%€21k▲ 95.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 84% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €63k
Fixed assets
€2k ▼ 34.7%
Current assets
€61k ▲ 46.9%
Equity and liabilities €63k
Equity
€44k ▲ 91.6%
Debt
€19k ▼ 12.3%
Debt's share of the balance-sheet total falls from 48.9% to 30.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€29k▲
2024 · €16k
Cash flow
€22k▲
2024 · €12k
Current ratio
3.17▲
2024 · 1.89
Debt to equity
0.44▼
2024 · 0.96
ROE
47.8%▲
2024 · 46.7%
ROA
33.2%▲
2024 · 23.9%
Interest coverage
53.46▲
2024 · 21.64
Debt ≤ 1 year
€19k▼
2024 · €22k
Income taxes
€6k▲
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 38 lines
Balance sheet
Code20242025
Assets
Total assets20/58€45k€63k▲
Fixed assets21/28€3k€2k▼
Tangible fixed assets22/27€3k€2k▼
Plant, machinery and equipment23€799€367▼
Furniture and vehicles24€2k€2k▼
Financial fixed assets28€55€55=
Current assets29/58€41k€61k▲
Amounts receivable within one year40/41€17k€40k▲
Trade receivables40€16k€40k▲
Other amounts receivable41€1k-
Cash at bank and in hand54/58€24k€20k▼
Deferred charges and accrued income490/1€150-
Equity and liabilities
Total equity and liabilities10/49€45k€63k▲
Equity10/15€23k€44k▲
Contributions10/11€2k€2k=
Profit (loss) carried forward14€21k€42k▲
Amounts payable17/49€22k€19k▼
Amounts payable within one year42/48€22k€19k▼
Current portion of amounts payable after more than one year42€6k-
Trade debts44€3k€529▼
Suppliers440/4€3k€529▼
Taxes, remuneration and social security45€6k€16k▲
Taxes450/3€6k€16k▲
Other amounts payable47/48€7k€2k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€1k▼
Other operating charges640/8€410-
Gross operating margin9900€17k€29k▲
Operating profit (loss)9901€15k€28k▲
Financial income75/76B€0€23▲
Recurring financial income75€0€23▲
Financial charges65/66B€760€542▼
Recurring financial charges65€760€542▼
Profit (loss) for the period before taxes9903€14k€27k▲
Income taxes67/77€4k€6k▲
Profit (loss) for the period9904€11k€21k▲
Profit (loss) for the period to be appropriated9905€11k€21k▲
Appropriation of the result
Profit (loss) to be appropriated9906€21k€42k▲
Profit (loss) brought forward from the previous period14P€10k€21k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Highest result since 2023net €21k ▲95.9%
Operating result €28k, net result €21k, both a record.
20-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 20 days late
2024
23-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Brigade Pironlaan 1241080 Sint-Jans-MolenbeekGround area
324 m²
Building footprint
120 m²
Volume, LiDAR
1,268 m³
Parcel 21526D0272/00B004, Brussels · tallest building 19.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
TAM PHARMA
since 20212.326.661.202
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21526D0272/00B004 | Brussels | 324 m² | 1 · 120 m² | 19.2 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CHASPIERRE HOLDING
BE 1019.183.255
Verviers · Eq €43,816
Pharma Poperinge
BE 0756.924.553
Gent · Eq €43,854
LINDA PHARMA
BE 1025.098.275
Etterbeek · Eq €43,688
Pharm@dvice
BE 0829.109.874
Fexhe-le-Haut-Clocher · Eq €44,047
JDS Pharma
BE 1012.963.476
La Louvière · Eq €43,542
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,582 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-12-2021
Fiscal year end30-09
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.